Market Place
Sourcing Support
Novartis pays Schrödinger $150M to form drug discovery pact
13 Nov 2024 //
PR NEWSWIRE
Schrödinger Reports Q3 2024 Financial Results
12 Nov 2024 //
BUSINESSWIRE
Schrödinger to Present at Jefferies London Healthcare Conference
04 Nov 2024 //
BUSINESSWIRE
Schrödinger Presents SGR-3515 Data at EORTC-NCI-AACR Symposium
23 Oct 2024 //
BUSINESSWIRE
Schrödinger to Present Preclinical Data at 2024 EORTC Symposium
09 Oct 2024 //
BUSINESSWIRE
Schrödinger Reports Inducement Grants Under Nasdaq Rule
18 Sep 2024 //
BUSINESSWIRE
Schrödinger to Present at Morgan Stanley Global Healthcare Conference
14 Aug 2024 //
BUSINESSWIRE
Schrödinger Reports Strong Second Quarter 2024 Financial Results
31 Jul 2024 //
BUSINESSWIRE
Schrödinger Expands Computational Tools For Predictive Toxicology
26 Jul 2024 //
BUSINESSWIRE
Schrödinger to Announce Second Quarter 2024 Financial Results on July 31
17 Jul 2024 //
BUSINESSWIRE
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
16 Jul 2024 //
BUSINESSWIRE
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
14 Jun 2024 //
BUSINESSWIRE
Schrödinger to Present at Jefferies Global Healthcare Conference
22 May 2024 //
BUSINESSWIRE
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
17 May 2024 //
BUSINESSWIRE
Schrödinger Reports First Quarter 2024 Financial Results
01 May 2024 //
BUSINESSWIRE
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
18 Apr 2024 //
BUSINESSWIRE
Schrödinger to Announce First Quarter 2024 Financial Results on May 1
10 Apr 2024 //
BUSINESSWIRE
Schrödinger Highlights Discovery of SGR-1505 at ACS National Meeting
20 Mar 2024 //
BUSINESSWIRE
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
19 Mar 2024 //
BUSINESSWIRE
Schrödinger Reports Strong Fourth Quarter and Full-Year 2023 Financial Results
28 Feb 2024 //
BUSINESSWIRE
Schrödinger to Participate in Upcoming Investor Conferences
20 Feb 2024 //
BUSINESSWIRE
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
16 Feb 2024 //
BUSINESSWIRE
Schrödinger to Announce Fourth Quarter and Full-Year 2023 Financial Results
14 Feb 2024 //
BUSINESSWIRE
Schrödinger takes a step forward with AlphaFold in drug R&D
01 Feb 2024 //
ENDPTS
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
19 Jan 2024 //
BUSINESSWIRE
Schrödinger Provides Update on Progress Across the Business Goals
08 Jan 2024 //
BUSINESSWIRE
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
19 Dec 2023 //
BUSINESSWIRE
Schrödinger Highlights Progress of Clinical Programs
14 Dec 2023 //
BUSINESSWIRE
Schrödinger Presents Data Supporting Advancement of SGR-1505 and SGR-2921
10 Dec 2023 //
BUSINESSWIRE
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
17 Nov 2023 //
BUSINESSWIRE
Schrödinger to Participate in Upcoming Investor Conferences
06 Nov 2023 //
BUSINESSWIRE
Schrödinger to Present New Data for SGR-1505 and SGR-2921
02 Nov 2023 //
BUSINESSWIRE
Schrödinger Reports Third Quarter 2023 Financial Results
01 Nov 2023 //
BUSINESSWIRE
Schrödinger to Host Pipeline Day on December 14, 2023
30 Oct 2023 //
BUSINESSWIRE
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
23 Oct 2023 //
BUSINESSWIRE
Schrödinger to Announce Third Quarter 2023 Financial Results on November 1
18 Oct 2023 //
BUSINESSWIRE
Schrödinger and Two City University of New York Colleges Awarded $1M NSF Grant
28 Sep 2023 //
BUSINESSWIRE
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
18 Sep 2023 //
BUSINESSWIRE
Schrödinger to Present at Morgan Stanley Global Healthcare Conference
05 Sep 2023 //
BUSINESSWIRE
Schrödinger Reports Second Quarter 2023 Financial Results
02 Aug 2023 //
BUSINESSWIRE
Replimune Announces Sander Slootweg will Depart from its Board of Directors
20 Jul 2023 //
FINANCE YAHOO
Schrödinger to Announce Second Quarter 2023 Financial Results on August 2
19 Jul 2023 //
BUSINESSWIRE
The more overhype, the harder you fall`: Schrödinger CEO warns on AI craze
05 Jul 2023 //
ENDPTS
Schrödinger to Present at Goldman Sachs 44th Annual Global Healthcare Conference
01 Jun 2023 //
BUSINESSWIRE
Schrödinger to Present at Jefferies Global Biopharma Conference
26 May 2023 //
BUSINESSWIRE
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
25 May 2023 //
BUSINESSWIRE
Schrödinger Reports Strong First Quarter 2023 Financial Results
04 May 2023 //
BUSINESSWIRE
Schrödinger Publishes Inaugural Corporate Sustainability Report
27 Apr 2023 //
BUSINESSWIRE
Schrödinger Reports Strong Fourth Quarter and Full-Year 2022 Financial Results
28 Feb 2023 //
BUSINESSWIRE
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17 Feb 2023 //
BUSINESSWIRE
Schrödinger Receives $111.3M Distribution from Sale of Nimbus’s TYK2 to Takeda
14 Feb 2023 //
BUSINESSWIRE
Schrödinger to Announce Fourth Quarter and Full-Year 2022 Financial Results
13 Feb 2023 //
BUSINESSWIRE
Schrödinger to Present at SVB Securities Global Biopharma Conference
31 Jan 2023 //
BUSINESSWIRE
Sai Life Sciences Enters Agreement with Schrodinger
13 Jan 2023 //
CONTRACT PHARMA
Sai inks agreement to set up Schrödinger`s first offshore Research Lab in India
10 Jan 2023 //
PR NEWSWIRE
Schrödinger Provides Update on Progress Across the Business
09 Jan 2023 //
BUSINESSWIRE
Schrödinger expands neuroscience work with BMS, Otsuka deals
09 Jan 2023 //
FIERCE BIOTECH
Schrodinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
16 Dec 2022 //
PRESS RELEASE
Schrodinger Presents New Preclinical Data Supporting Advancement of SGR-2921
12 Dec 2022 //
BUSINESSWIRE
Schrödinger to Present at Piper Sandler 34th Annual Healthcare Conference
21 Nov 2022 //
BUSINESSWIRE
